You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1253-ESGO CONCERVE study demonstrates that clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4/miR124–2 DNA methylation

Article metrics

Article menu

Download PDFPDF

Cervical cancer
2022-RA-1253-ESGO CONCERVE study demonstrates that clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4/miR124–2 DNA methylation
Free

 

Online download statistics by month:

Online download statistics by month: October 2022 to October 2024

AbstractFullPdf
Oct 20221000
Nov 20223906
Dec 202244012
Jan 20232902
Feb 20231201
Mar 2023402
Apr 20231001
May 2023800
Jun 2023401
Jul 20231504
Aug 2023603
Sep 20231003
Oct 20236608
Nov 20231208
Dec 20233304
Jan 20242201
Feb 20242201
Mar 2024800
Apr 20241402
May 20241205
Jun 2024601
Jul 2024403
Aug 2024802
Sep 20241004
Oct 2024200
Total410074